{
  "document_id": "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_I/Development/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement.pdf",
  "text_length": 65673,
  "chunk_count": 88,
  "vector_store_path": "output/vector_stores/EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_Development Agreement",
  "summary": "unenforceable part or provision shall, provided that it does not affect the essence of this Agreement, be replaced with a revision which\naccomplishes, to the greatest extent possible, the original commercial purpose of such part or provision in a valid and enforceable manner, and the\nbalance of this Agreement shall remain in full force and effect and binding upon the Parties hereto.\n15.8 Assignment . The terms and provisions hereof shall inure to the benefit of, and be binding upon the Parties and their respective\nsuccessors and permitted assigns. The Parties shall not assign, encumber or otherwise transfer this Agreement or any part of it to any Third Party,\nwithout the prior written consent of the other Party. Notwithstanding the foregoing, each Party may assign the rights and obligations under this\nAgreement in whole, without consent of the other Party, to a Third Party or Affiliate in connection with the transfer or sale of all or substantially all\n\nrespect thereof, and including those levied on, or measured by, or referred to as, income, gross receipts, profits, capital, transfer, land transfer, sales,\ngoods and services, harmonized sales, use, value-added, excise, stamp, withholding, business, franchising, property, development, occupancy,\nemployer health, payroll, employment, health, social services, education and social security taxes, all surtaxes, all customs duties and import and\nexport taxes, countervail and anti-dumping, all license, franchise and registration fees and all employment insurance, health insurance and\ngovernment pension plan premiums or contributions.\n1.36 \u201cTerm \u201d shall have the meaning ascribed to this term in Section 11.1 of this Agreement.\n4\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\nCONFIDENTIAL\n11. TERM AND TERMINATION\n11.1 Term . The term of this Agreement shall automatically become effective upon the occurrence of (i) ETON executing a commercial\nsupply agreement with a contract manufacturing organization within forty-five (45) days of the Execution Date, provided that ETON has exercised\nbest efforts to execute such agreement and the failure to execute is solely caused by the refusal or inability of the proposed manufacturing\norganization to sign a reasonable agreement\u037e and (ii) acceptance for review of the Dossier or marketing application for [ * * * ] by the FDA no later\nthan September 2, 2019 (such date, the \u201c Effective Date \u201d) and shall end upon the termination or expiration of the Agreement as set forth in Section\n11 (the \u201c Term \u201d). For avoidance of doubt, all rights conferred to ETON under this Agreement for the purpose of allowing ETON to Market the\n\nthereof.\n1.5 \u201cAucta Indemnified Parties \u201d shall have the meaning ascribed to the term in Section 13.2 of this Agreement.\n1.6 \u201cBreaching Party \u201d shall have the meaning ascribed to the term in Section 11.2 of this Agreement.\n1.7 \u201cBusiness Day \u201d means any day, other than Saturday, Sunday or other day on which commercial banks are authorized or required to\nclose in New York, New York or Rome, Italy.\n1.8 \u201cCalendar Quarter \u201d means a three (3) consecutive month period ending on March 31, June 30, September 30 or December 31.\n1.9 \u201cClaim \u201d includes a claim, notice, demand, action, proceeding, litigation, prosecution, arbitration, investigation, judgment, award,\ndamage, loss, cost, expense or liability however arising, whether present, unascertained, immediate, future or contingent, whether based in contract,\ntort or statute and whether involving a Third Party or a Party or otherwise.\n1.10 \u201cConfidential Information \u201d shall have the meaning ascribed to the term in Section 9.2 of this Agreement.",
  "parties": "unenforceable part or provision shall, provided that it does not affect the essence of this Agreement, be replaced with a revision which\naccomplishes, to the greatest extent possible, the original commercial purpose of such part or provision in a valid and enforceable manner, and the\nbalance of this Agreement shall remain in full force and effect and binding upon the Parties hereto.\n15.8 Assignment . The terms and provisions hereof shall inure to the benefit of, and be binding upon the Parties and their respective\nsuccessors and permitted assigns. The Parties shall not assign, encumber or otherwise transfer this Agreement or any part of it to any Third Party,\nwithout the prior written consent of the other Party. Notwithstanding the foregoing, each Party may assign the rights and obligations under this\nAgreement in whole, without consent of the other Party, to a Third Party or Affiliate in connection with the transfer or sale of all or substantially all\n\nnotice by the proper giving of notice hereunder:\nIf to ETON, to:\nETON Pharmaceuticals, Inc.\n21925 W. Field Pkwy, Suite 235\nDeer Park, Illinois, USA\nAttention: CEO\nWith a copy (which shall not constitute notice) to:\nETON Pharmaceuticals, Inc.\n21925 W. Field Pkwy, Suite 235\nDeer Park, Illinois, USA\nAttention: Legal\nif to Aucta, to:\nAucta Pharmaceuticals, Inc.\n71 Suttons Lane\nPiscataway, NJ 08854\nAttention: CEO\n15.4 Relationship of Parties . The status of the Parties under this Agreement shall be that of independent contractors, without the authority\nto act on behalf of or bind each other. Nothing in this Agreement shall be construed as establishing a partnership or joint venture relationship\nbetween the Parties hereto. No Party shall have the right to enter into any agreements on behalf of the other Party, nor shall it represent to any\nperson that it has such right or authority. All persons employed by a Party shall be employees of such Party and not of the other Party and all costs\n\nperson that it has such right or authority. All persons employed by a Party shall be employees of such Party and not of the other Party and all costs\nand obligations incurred by reason of any such employment shall be for the account and expense of such Party.\n20\nSource: ETON PHARMACEUTICALS, INC., 10-Q, 11/14/2019\n\nDate (later defined) occurs.\nNOW, THEREFORE , in consideration of the foregoing premises and the representations, warranties, covenants and agreements herein\ncontained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, ETON and Aucta, intending\nto be legally bound, hereby agree as follows:\n1. DEFINITIONS.\nFor the purposes of this Agreement, the following terms whether used in singular or plural form shall have the meanings as defined below:\n1.1 \u201cAffiliates \u201d means, with respect to a Party or any Third Party, any corporation, firm, partnership or other entity that controls, is\ncontrolled by or is under common control with such entity. For the purposes of this definition, \u201ccontrol\u201d means the ownership of at least 50% of the\nvoting share capital of an entity or any other comparable equity or ownership interest.\n1.2 \u201cANDA Litigation \u201d shall have the meaning ascribed to the term in Section 7.5.2 of this Agreement.",
  "key_terms": "unenforceable part or provision shall, provided that it does not affect the essence of this Agreement, be replaced with a revision which\naccomplishes, to the greatest extent possible, the original commercial purpose of such part or provision in a valid and enforceable manner, and the\nbalance of this Agreement shall remain in full force and effect and binding upon the Parties hereto.\n15.8 Assignment . The terms and provisions hereof shall inure to the benefit of, and be binding upon the Parties and their respective\nsuccessors and permitted assigns. The Parties shall not assign, encumber or otherwise transfer this Agreement or any part of it to any Third Party,\nwithout the prior written consent of the other Party. Notwithstanding the foregoing, each Party may assign the rights and obligations under this\nAgreement in whole, without consent of the other Party, to a Third Party or Affiliate in connection with the transfer or sale of all or substantially all\n\nAgreement in whole, without consent of the other Party, to a Third Party or Affiliate in connection with the transfer or sale of all or substantially all\nof its business or in the event of a merger, consolidation or change in control provided that the assignee assumes in writing and becomes directly\nobligated to the other Party to perform all of the obligations of assignor under this Agreement.\n15.9 Waiver . No waiver of a breach or default hereunder shall be considered valid unless in writing and signed by the Party giving such\nwaiver, and no such waiver shall be deemed a waiver of any subsequent breach or default of the same or similar nature.\n15.10 Survival . Any provision which by its terms is intended to survive the termination or expiration of this Agreement will survive the\ntermination or expiration of this Agreement and remain in full force and effect thereafter.\n\nand Cosmetic Act\u037e\n12.1.5 there is no Claim, suit, investigation, action or proceeding pending or threatened against ETON before any court,\ngovernmental agency, or arbitration panel which may in any way materially adversely affect the performance of its obligations hereunder or\ntransaction contemplated by this Agreement\u037e\n12.1.6 it has not and will not enter into any contract or any other transaction with any Third Party or Affiliate that conflicts\nwith or derogates from its undertakings hereunder\u037e\n12.1.7 it has and will at all times during Term have requisite expertise, experience, personnel, equipment and skill to perform its\nobligations hereunder\u037e and\n12.1.8 it has obtained or will maintain to the extent necessary for its performance of activities with respect to the Products\nunder this Agreement all required licenses, authorizations, and approvals required by federal, state, or local governmental authorities, including\n\nCONFIDENTIAL\n11. TERM AND TERMINATION\n11.1 Term . The term of this Agreement shall automatically become effective upon the occurrence of (i) ETON executing a commercial\nsupply agreement with a contract manufacturing organization within forty-five (45) days of the Execution Date, provided that ETON has exercised\nbest efforts to execute such agreement and the failure to execute is solely caused by the refusal or inability of the proposed manufacturing\norganization to sign a reasonable agreement\u037e and (ii) acceptance for review of the Dossier or marketing application for [ * * * ] by the FDA no later\nthan September 2, 2019 (such date, the \u201c Effective Date \u201d) and shall end upon the termination or expiration of the Agreement as set forth in Section\n11 (the \u201c Term \u201d). For avoidance of doubt, all rights conferred to ETON under this Agreement for the purpose of allowing ETON to Market the"
}